3[1]Patrick V,Anna L,Aliso C,et al.Accumulation of an endogenous inhibitors of nitric oxide synthesis in chronic renal failure[J].Lancet,1992,339:572.
4[2]Rainle AE,Bedford L,Simpson AW,et al.Hyperparathyroidism,platlet intracellular free calcium and hypertension in chronic renal failure[J].Kidney Int,1993,43:702-705.
5[3]Morena MD.Effect of novel adsorbent on cytokine responsiveness to uremic plasma[J].Kidney Int,2003,63:1150-1154.
6Jankova T ,Mitas JA . Low prekallikrein and high angiotensin converting enzyme activity in patients with chronic renal failure on hemodialysis.Nephron Dial Transplant,1991;6(Suppl 3):6
7HEMO Study Group (prepared by Daugirdas JT,et al).Methods of estimating the equilibrated Kt/V :data from the HEMO study.Kidney Int ,1997;52:1395
9Duranti E, Inperiali P, Sasdeli M. Is Hypertension a mortality risk factor in dialysis? Kidney Int,2003 ,63 :1462-1467.
10Tozawa M, Iseki K, Iseki C ,et al. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic heamodialysis. Kidney Int ,2002,61:717-726.
5Inrig J K, Patel U D, Gillespie B S, et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients[J]. Am J Kidney Dis, 2007,50 ( 1 ): 108- 109.
6Ward R A, Ronco C. Dialyzer and machine technologies: application of recent advances to clinical practice [J]. Blood Purif, 2006,24 (1) : 6-10.
7Yarnamoto N,Yasue H,Mizuno Y,et al.Aldoterone is produced from ventricles in patients with essential hypertension[J].Hypertension,2002,39(5):958.
